NORMAL SITUATION

LucasFarma

Export PDF
Financial year 2024 · closed on 30/06/2024
Net result
23,8 k €
+185.8% YoY
Gross margin
114,1 k €
+50.6% YoY
Equity
140,2 k €
+20.5% YoY

Company — Normal situation.

What does LucasFarma do?

LucasFarma is a company registered in Belgium.

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0736.962.844
Legal form
Private limited company
Contributed capital
100 000,00 €
Latest accounts
30/06/2024
Joint committees (1)
  • 313
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDAHealthy social debts
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 4 financial years

2024202320222021
Income statement
Gross margin114,1 k €75,7 k €49,6 k €125,8 k €
EBITDA48,9 k €31,6 k €20,2 k €52,6 k €
Operating result30,9 k €12,7 k €1,6 k €19 k €
Net result23,8 k €8,3 k €-2,9 k €11 k €
Balance sheet
Equity140,2 k €116,4 k €108,1 k €111 k €
Total assets421,5 k €392,1 k €386,4 k €378,3 k €
Cash223,5 k €182,4 k €148,2 k €135,6 k €
Debts281,1 k €275,7 k €278,4 k €267,3 k €
Other
Workforce–0,9 ETP0,5 ETP0,7 ETP
Governance

Board of directors

Seen on filing of 30/06/2024 · 3 active

Active mandates

Apotheek An Sofie Stragier

Director · 0472.709.605

Represented by An Sofie Stragier

Active
DELABON

Director · 0842.268.321

Represented by Katleen Bonte

Active
STEELAND CONSULT

Director · 0841.893.583

Represented by Pascal Steeland

Active
Annual accounts

Full financial information

2024202320222021
Type of accountMicro modelAbridged modelAbridged modelAbridged model
Start of the financial year01/07/202301/07/202201/07/202125/10/2019
Closing of the financial year30/06/202430/06/202330/06/202230/06/2021
Length of the financial year12 months12 months12 months21 months
Filing date02/01/202531/01/202430/01/202331/01/2022
General meeting21/12/202416/12/202317/12/202231/12/2021
Currency of the financial yearEUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

4 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Micro model30/06/202421/12/202402/01/2025DutchPDF
Abridged model30/06/202316/12/202331/01/2024DutchPDF
Abridged model30/06/202217/12/202230/01/2023DutchPDF
Abridged model30/06/202131/12/202131/01/2022DutchPDF
Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/06/2024 · 3 active

Active mandates

Apotheek An Sofie Stragier

Director · 0472.709.605

Represented by An Sofie Stragier

Active
DELABON

Director · 0842.268.321

Represented by Katleen Bonte

Active
STEELAND CONSULT

Director · 0841.893.583

Represented by Pascal Steeland

Active
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Dissolution07/07/2025
    RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ...
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 202423,8 k €↑
  2. 2023
    Annual accounts 20238,3 k €↑
  3. 2022
    Annual accounts 2022-2,9 k €↓
  4. 2021
    Annual accounts 202111 k €